U.S. Markets closed

Mylan N.V. (MYL)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
39.72-0.11 (-0.28%)
At close: 4:00PM EDT
People also watch
  • 37% institutional ownership
  • In the short-term MYL does not seem to be like a good trade. check out aw-esomeSTOCKS, its a pretty reliable service. of course you have to do your own due diligence, but they generally point you in the right direction.
  • Ouch
    When is the generic drug makers going to be back in favor?
    Mylan down on a good tape
    This is unbelievable
  • Lets be clear here. This company does not work for Investors this company works for Corporate and insider greed. $100,000,000 to the CEO for poor performance is despicable.
  • Two most recent analysts..GS, very impressed with their balance sheet...Barclay says overweight, ups his PT...MYL still not even above $40?!?!? Unbelievable!
  • Mylan up and Teva down
  • I'm new to the stock and would like to know what value proposition other than a sale moving forward. Looks like another Valeant in the making.
  • Ouch
    This was way up in the pre-market trading. I just got back and now it has dropped
    What the heck has happened?
  • The time for a corporate cleansing is long overdue
  • Time to squeeze the short sellers out of Mylan once and for all
  • 49 target today. lol not as rosey as analysts were once portraying. Another liberal lie
  • in light of the $100,000,000 CEO greed if this company misses target new investers will invest else where. Never before has such greed has been displayed
  • I agree with you guys hoping some big shareholders turn activist and force some changes. However is it not the SEC's responsibility to protect shareholders of public companies from what basically amounts to theft or fraud? I realize MYL is no longer US based but they trade on our exchanges so they have to follow certain rules
  • VRX and ENDP earnings rocked...MYL up next...Wonder if shorts cover in advance
  • Did any read Gardeners (Motley Fool) statement on Mylan? Bought 2015 then averaged down in 2016 by adding then the article identifies 10 other drug companies. So 1 in 10 and it appears he bought 2 years early still in the red and falling. The whole scenario does not make sence for timeliness. Any one can justify a goof over a two year period.
  • Mylan management skimmed off ~25% of net income for themselves.... and still no dividends. This is a travesty, and as a shareholder, I feel ripped off. Surprised big holders are not more outraged and/or going "activist." I have spoken to shareholder services about managements tone deafness, and seeming lack of regard for shareholders, but obviously get nowhere. I guess so long as Coury, Bresch, et al can continue to pillage the proceeds of the company, they will continue to do so... as their continued greed and missteps seemingly have no consequences for them. Are other shareholders as frustrated as I am?
  • MYL is starting to look a bit short-squeezy-like
  • $100,000,000 CEO hope shareholders got their moneys worth.
  • If MYL shareholders were smart, they would dump Heather, Coury and the rest of its directors...........$100 million + for Heather, Coury, and the rest of MYL directors.........Shareholders should revolt against this raping of company profits...and still no dividends......amazing
  • lot of $ do they pay off analysts to hype it while insiders rob investers.